- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02461693
Evaluating the Role of Expectations in Response to Caffeine Consumption: An RCT
13. juni 2017 oppdatert av: David Allison, Phd, University of Alabama at Birmingham
Evaluating the Role of Expectations in Response to Caffeine Consumption: A Randomized Control Trial
The purpose of this project is to examine the effect of expectancy on mood and alertness after consumption of caffeine "treatment" or placebo "control" pill, given that participants know their probability for receiving the caffeine versus placebo pill.
Participants will be randomly assigned a probability (ranging from 0-100%) of receiving caffeine vs. placebo, and this probability will be revealed to them before consumption of the assigned pill and subsequent cognitive testing.
At the time of consumption, neither study staff administering the intervention nor participants will know for certain which pill is given to each participant.
Pill assignment will depend on pre-determined randomization probabilities, which will be provided and assigned by the study statistician.
By revealing participants' individual probability of receiving the caffeine pill, we will induce positive or negative expectancies regarding likelihood for receipt of the caffeine pill.
These experimental manipulations will: 1) estimate the effect of expectancy on cognitive and affective outcomes, and 2) allow for a more direct estimate of the effect of the caffeine pill under real-world conditions than would a conventional randomized trial.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Faktiske)
205
Fase
- Ikke aktuelt
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- 18 years-old or older
- available to participate on the dates specified
- willing to take a caffeine or placebo pills at study session
- willingness to abstain from caffeine for 12 hours prior to study visit (8:30pm-8:30am)
- UAB employees or students with some college education (including current enrollment)
Exclusion Criteria:
- self-reported use of ADHD medication
- self-reported use of anxiety medication
- self-reported use of sleep medication
- self-reported use of nicotine products
- self-reported lactose intolerance
- self-reported uncorrected vision
- self-reported pregnancy or trying to become pregnant
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Caffeine
One-time treatment with 200mg caffeine pill
|
200mg delivered as pill; one-time dose
|
Placebo komparator: Placebo
One-time treatment with lactose-based placebo pill
|
Lactose-based pill; one-time dose
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Mood State Score on POMS-2 Test
Tidsramme: 30 minutes post pill consumption
|
Profile of Mood States (POMS-2)- "Volunteers rated a series of 65 mood-related adjectives with regard to how they were feeling "right now" on a scale of 0 (not at all) to 4 (extremely).
The adjectives factor into six mood sub-scales: Tension-Anxiety; Depression-Dejection; Anger-Hostility; Vigor-Activity; Fatigue-Inertia; Confusion-Bewilderment and a Total Mood Disturbance score which aggregates the six sub-scales into a single variable."
- from our publication.
The minimum and maximum possible raw scores were: 0 and 40 for Tension-Anxiety, 0 and 52 for Depression-Dejection, 0 and 44 for Anger-Hostility, 0 and 36 for Vigor-Aactivity, 0 and 24 for Fatigue-Inertia, 0 and 40 for Confusion-Bewilderment, -36 and 200 for Total Mood Disturbance, and 0 and 24 for Friendliness.
For Friendliness and Vigor-Activity, the more positively a person feels, the higher the score.
For all other sub-scales and Total Mood Disturbance, the more negatively a person feels, the higher the score.
|
30 minutes post pill consumption
|
Vigilance Score on Computer-based Test Using Random, Visual Stimulus: Proportion Correct (Out of 60)
Tidsramme: 45 to 105 minutes post pill consumption
|
Scanning Visual Vigilance Test.
"This test assesses vigilance, ability to sustain attention during long, boring, continuous tasks that generate minimal cognitive load (Fine et al, 1994; Lieberman et al, 1998; 2002).
The volunteer continuously scans a computer screen to detect an infrequent, difficult-to-detect stimulus that appears at random intervals and locations for 2 s.
On average, a stimulus was presented once per minute.
Upon detection of the stimulus, the volunteer pressed the space bar as rapidly as possible.
Whether a stimulus was detected and time required for detection was recorded.
Responses before or after stimulus occurrence were false alarms.
The test lasted 60 minutes."
- from our publication
|
45 to 105 minutes post pill consumption
|
Vigilance Score on Computer-based Test Using Random, Visual Stimulus: Number Correct, Number of False Alarm Hits
Tidsramme: 45 to 105 minutes post pill consumption
|
Scanning Visual Vigilance Test.
"This test assesses vigilance, ability to sustain attention during long, boring, continuous tasks that generate minimal cognitive load (Fine et al, 1994; Lieberman et al, 1998; 2002).
The volunteer continuously scans a computer screen to detect an infrequent, difficult-to-detect stimulus that appears at random intervals and locations for 2 s.
On average, a stimulus was presented once per minute.
Upon detection of the stimulus, the volunteer pressed the space bar as rapidly as possible.
Whether a stimulus was detected and time required for detection was recorded.
Responses before or after stimulus occurrence were false alarms.
The test lasted 60 minutes."
- from our publication
|
45 to 105 minutes post pill consumption
|
Vigilance Score on Computer-based Test Using Random, Visual Stimulus: Mean Time to a Correct Hit
Tidsramme: 45 to 105 minutes post pill consumption
|
Scanning Visual Vigilance Test.
"This test assesses vigilance, ability to sustain attention during long, boring, continuous tasks that generate minimal cognitive load (Fine et al, 1994; Lieberman et al, 1998; 2002).
The volunteer continuously scans a computer screen to detect an infrequent, difficult-to-detect stimulus that appears at random intervals and locations for 2 s.
On average, a stimulus was presented once per minute.
Upon detection of the stimulus, the volunteer pressed the space bar as rapidly as possible.
Whether a stimulus was detected and time required for detection was recorded.
Responses before or after stimulus occurrence were false alarms.
The test lasted 60 minutes."
- from our publication
|
45 to 105 minutes post pill consumption
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Etterforskere
- Hovedetterforsker: David B Allison, PhD, University of Alabama at Birmingham
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart
1. juni 2015
Primær fullføring (Faktiske)
1. oktober 2015
Studiet fullført (Faktiske)
1. oktober 2015
Datoer for studieregistrering
Først innsendt
1. juni 2015
Først innsendt som oppfylte QC-kriteriene
2. juni 2015
Først lagt ut (Anslag)
3. juni 2015
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
12. juli 2017
Siste oppdatering sendt inn som oppfylte QC-kriteriene
13. juni 2017
Sist bekreftet
1. juni 2017
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- F150410009
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Ja
IPD-planbeskrivelse
Raw de-identified data will be posted as a replication data set on ICPSR after publication of results in a journal.
Data will be free to download and accessible to anyone with access to ICPSR replication data sets.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
produkt produsert i og eksportert fra USA
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .